Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    tanezumab
Show Display Options
Rank Status Study
1 Terminated Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip
Conditions: Osteoarthritis;   Arthritis
Interventions: Drug: NSAID;   Biological: tanezumab
2 Completed A Study of Tanezumab in Adults With Chronic Low Back Pain
Condition: Low Back Pain
Interventions: Biological: Tanezumab 20 mg IV;   Drug: Placebo for naproxen;   Biological: Tanezumab 10 mg IV;   Biological: Tanezumab 5 mg IV;   Biological: Placebo for tanezumab;   Drug: Naproxen
3 Terminated Extension Study Of Tanezumab In Osteoarthritis
Condition: Osteoarthritis
Intervention: Biological: tanezumab
4 Terminated Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study
Conditions: Osteoarthritis;   Arthritis;   Pain
Interventions: Biological: Placebo IV;   Biological: Placebo SC;   Biological: Tanezumab SC;   Biological: Tanezumab IV
5 Recruiting Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain
Condition: Low Back Pain
Interventions: Drug: Celecoxib;   Biological: Tanezumab 5 mg;   Biological: Tanezumab 10 mg;   Drug: Placebo for celecoxib;   Biological: Placebo for tanezumab
6 Completed Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected
Conditions: Osteoarthritis Pain;   Chronic Low Back Pain;   Pain Due to Interstitial Cystitis
Interventions: Other: placebo;   Biological: tanezumab
7 Terminated Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip
Condition: Osteoarthritis
Interventions: Biological: tanezumab;   Drug: diclofenac;   Other: IV placebo
8 Recruiting Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee
Conditions: Osteoarthritis, Knee;   Osteoarthritis, Hip
Interventions: Other: Placebo;   Biological: Tanezumab 2.5 mg;   Biological: Tanezumab 2.5mg/5mg
9 Terminated A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy
Condition: Diabetic Peripheral Neuropathy
Interventions: Biological: Tanezumab;   Biological: placebo
10 Recruiting Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
Conditions: Chronic Pain;   Osteoarthritis, Hip;   Osteoarthritis, Knee
Interventions: Drug: NSAID;   Biological: Tanezumab 2.5 mg;   Biological: Tanezumab 5 mg
11 Completed Tanezumab in Osteoarthritis Of The Hip
Conditions: Arthritis;   Osteoarthritis;   Osteoarthritis, Hip
Interventions: Biological: tanezumab;   Biological: Placebo
12 Terminated Long Term Safety Study of Tanezumab in Chronic Low Back Pain
Condition: Low Back Pain
Interventions: Biological: Tanezumab 20 mg;   Biological: Tanezumab 10 mg
13 Recruiting A Phase 3 Study of Tanezumab for Chronic Low Back Pain
Condition: Low Back Pain
Interventions: Biological: Placebo to Week 16; tanezumab 5mg SC;   Biological: Placebo to Week 16, tanezumab 10 mg SC;   Biological: Tanezumab 5 mg SC;   Biological: Tanezumab 10 mg SC;   Biological: Tramadol PR oral
14 Terminated Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis
Condition: Chronic Pancreatitis
Interventions: Biological: Tanezumab;   Other: Placebo
15 Terminated Tanezumab and Nerve Function In Arthritis Patients
Condition: Osteoarthritis
Interventions: Biological: tanezumab;   Other: Placebo
16 Terminated Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis
Condition: Osteoarthritis
Intervention: Biological: Tanezumab
17 Completed A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
Conditions: Neoplasm Metastasis;   Palliative Care
Interventions: Drug: Tanezumab 10 mg IV;   Drug: IV Placebo for tanezumab
18 Terminated A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections
Conditions: Osteoarthritis, Knee;   Osteoarthritis, Hip
Interventions: Biological: Tanezumab 2.5 mg;   Biological: Tanezumab 5 mg;   Biological: Tanezumab 10 mg
19 Terminated A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis
Condition: Endometriosis
Interventions: Biological: Tanezumab;   Drug: Placebo
20 Recruiting Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.
Condition: Osteoarthritis of Hip and Knee.
Interventions: Drug: Tanezumab;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years